These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Immunologic features of genitourinary cancer. Javadpour N Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366 [No Abstract] [Full Text] [Related]
9. Immunobiologic defense -- the view of the surgeon. Eiseman B Ann Chir Gynaecol; 1977; 66(2):63-71. PubMed ID: 301374 [No Abstract] [Full Text] [Related]
10. Need for immunologic stimulators during immunosuppression produced by major cancer surgery. Cole WH; Humphrey L Ann Surg; 1985 Jul; 202(1):9-20. PubMed ID: 3893336 [TBL] [Abstract][Full Text] [Related]
11. [Immunology of malignant neoplasms of the urogenital system]. Stratev S Khirurgiia (Sofiia); 1988; 41(1):46-52. PubMed ID: 3285081 [No Abstract] [Full Text] [Related]
13. [Value of alpha-globulin as a biological tracer in urogenital cancer]. Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304 [No Abstract] [Full Text] [Related]
14. Alterations of host defenses: the key to the multifaceted spectrum of infections in immunocompromised patients. Glauser MP Recent Results Cancer Res; 1991; 121():321-8. PubMed ID: 1857870 [TBL] [Abstract][Full Text] [Related]